Sentences with phrase «year survival rate for»

If detected early, the five - year survival rate for cervical cancer is almost 100 %.

An interesting article in Bloomberg Business Week (Oct 21 - 27, 2013) revealed that the 27 - year survival rate for community banks in the United States were significantly higher than for larger banks.

For example, the five year survival rate for someone with lung cancer is 54 % but only if the disease is detected early and still localized within the individual's lungs.

The five - year survival rate for people whose melanoma is detected and treated before it spreads to the lymph nodes is 99 percent, the group says.

In fact, the 25 - year survival rate for patients with papillary thyroid cancer, the most common type, is 95 %.

For melanoma, the deadliest skin cancer by far, the five - year survival rate for patients whose lesion is detected early is about 98 percent in the United States, according to the Skin Cancer Foundation.

In reality, the average five - year survival rate for cancer is 69 percent.

The five - year survival rate reduces * to approximately 93 % amongst patients that are diagnosed with stage two breast cancer and the five - year survival rate for patients with stage three breast cancer is 72 %.

But the number of women surviving this advanced stage of the disease is rising: A study published this month in Cancer Epidemiology, Biomarkers & Prevention found that the five - year survival rate for women initially diagnosed with metastatic breast cancer doubled from 18 % in the early 1990s to 36 % in the last decade or so.

Socioeconomic factors The five - year survival rate for white women is approximately 90 %; for African - American women it's roughly 77 %.

The overall five - year survival rate for ovarian cancer is 31 percent, which means that 69 percent of patients diagnosed this year will not be alive in 2016, highlighting the urgent need for a better understanding of the disease.

The five - year survival rate for those on dialysis is ~ 35 %.

The overall 5 - year survival rate for breast cancer is now 89 % — a dramatic improvement over the early 1960s when the rate was 63 %.

Researchers note an 87 % 8 - year survival rate for those who were nonsmokers compared with smokers who experienced an 83 % 8 - year survival rate with a mortality hazard ratio of 2.08 (95 % CI, 1.4 — 3.1; P <.001); however, the effects of smoking were also based on advancing age and other comorbidities.

When I was diagnosed in 2013, the five - year survival rate for pancreatic cancer rate

Today, the overall 5 year survival rate for childhood cancer is close to 80 %.

The 5 - year survival rate for localized (stage I and II) melanoma is 98 %; however, this drops to 17 % in cases where cancer has metastasized to distant sites or organs.

The 5 - year survival rate for breast cancer when caught early is 98 %.

The five - year survival rate for patients with advanced melanoma who got other treatments was 16.6 percent between 2005 and 2011, according to the National Cancer Institute.

The five - year survival rate for those with metastatic melanoma treated with nivolumab is 34 percent.

The one - year survival rate for patients on dialysis was 50 percent in 1995 and 95 percent in 2013; survival for patients on a ventilator was 49 percent in 1994 and 94 percent in 2013.

The five - year survival rate for HLHS patients is approximately 50 to 70 percent.

In addition, the study showed that the 5 - year survival rate for selected older patients with advanced lung cancer who were treated with surgical therapy was 29.9 % for Stage III and 26.7 % for Stage IV.

The five - year survival rate for glioblastoma is 4 percent for those age 55 to 64, according to the American Cancer Society.

The five - year survival rate for children with glioblastoma is 25 percent.

Using this, the team found that three - year survival rates for the best matched / lowest risk donor and recipient pairs could be greater than 87 percent and less than 74 percent for the worst - matched / highest - risk group.

Five - year survival rates for pancreatic cancer have inched up from 6 to 9 percent in recent years.

Five - year survival rates for children with HLH hover at about 50 %, reinforcing the need for more research.

Five - year survival rates for low - grade (grade 1) tumors can be as high as 95 percent; for grade 4 tumors, five - year survival plummets to about 5 percent, she said.

Five - year survival rates for regional (lymph nodes) and distant (other organs / lymph nodes) stage melanomas are 63 percent and 20 percent, respectively.2

Not exact matches

The status quo for hundreds of thousands of people, meanwhile, is untenable: More than 333,000 Americans will be diagnosed this year in any of four cancer types in which the five - year survival rate remains lower than 20 %, and in all, nearly 600,000 U.S. deaths are expected from cancer in 2016.

A type of certified «socially responsible» company called a B Corp has higher two - and five - year survival rates than traditional companies, according to B Lab, the sanctioning organization for B Corps.

However, the five - year survival rate was 16 % for those treated with immunotherapy.

When jaundice mounts, and liver failure is likely, a liver transplant may offer hope, for the five - year survival rate after this operation with the use of cyclosporine has been reported to be better than 60 percent.

Over the last decade, the ten year survival rate increased by 11 per cent for all cancers combined, but the rates differ wildly between types of cancer.

As the NHS was often poor at detecting cancer, this made for poor one year survival rates.

Sara Hiom, Cancer Research UK's director of health information, said: «Survival rates for breast cancer have been improving for more than 20 years - eight out of ten patients now survive more than five years.

A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, and one of the most deadliest with a less than 10 percent, five - year survival rate.

Results of the trial, reported in the May 31 issue of the New England Journal of Medicine and presented at the American Society for Clinical Oncology 2015 annual meeting, also showed that after a year, the nivolumab group had nearly double the survival rate (42 percent) of the chemotherapy patients (24 percent).

Prostate cancer is highly curable, with a 94 percent 15 - year relative survival rate for early stages.

At five years following RT, survival rates for men who received brachytherapy alone were comparable to those who underwent more aggressive radiation treatment.

In examining the STS - CMS linked data, researchers found that the median survival following lung cancer surgery for pathologic Stage I (early stage) was 6.7 years, almost 2 years longer than the benchmark 5 - year survival rate.

With a three - year survival rate of 94.39 percent for all adult kidney recipients — above the 92.62 percent national average — UCSF has more patients on the kidney transplant waiting list than any other U.S. transplant center.

He noted there is a huge unmet need for this type of precision medicine among lung transplant patients, who experience the shortest of all survival rates, often running into transplant trouble within five years.

Studies show that PD - 1 inhibitors are effective for a larger proportion of melanoma patients than ipilimumab alone — and, in combination with that drug, they achieve a two - year survival rate of 80 percent.

Of the 2,103 living donor transplant and 46,674 deceased donor transplants recipients analyzed, the three - year patient survival rate for deceased donor recipients was 78 percent compared with 83 percent for living donor transplants that were performed at experienced centers.

The difference in survival became even greater with longer follow - up, with a five - year survival rate of 71 percent for deceased donor recipients, compared with 78 percent for living donor transplants at an experienced center.

The five year disease - free and overall survival rates for patients with high - risk malignant germ cell tumours remains less than 50 %, and so accurate diagnosis and monitoring is crucial to improving outcomes for patients.

The researchers found that the 5 - year survival rate of patients in the lowest BMI category was around 76 % compared with almost 93 % for those in the highest BMI category.

The researchers found that compared to measles - unvaccinated children, survival rates for measles - vaccinated children increased by a staggering 28 % in the first 12 months of follow - up and 18 % by five years of age.